Generate a tailored SOP for Dr. Ernesta Neri. Improve your application with a focused, well-structured draft.
Dr. Ernesta Neri is an Associate Professor in the Cumming School of Medicine at the University of Calgary and a full member of the Arnie Charbonneau Cancer Institute. She obtained her medical degree and PhD in Molecular Oncology from Magna Græcia University in Italy. An expert in multiple myeloma, Dr. Neri's work centers on drug development and identifying genomic signatures that predict responses to anti-multiple myeloma agents. Her studies aim to advance the understanding of myelomagenesis and drug resistance, utilizing a comprehensive myeloma tissue bank for investigational purposes. Notably, Dr. Neri's research has led to promising therapeutic strategies, including the application of proteasome inhibitors and PARP inhibitors in clinical trials. She is recognized for her contributions by the International Myeloma Society with the Ken Anderson Young Investigator Award and is actively involved in clinical trials and translational research focused on multiple myeloma.
University of Calgary • Calgary, AB, Canada
Joined as a faculty member focusing on research in multiple myeloma, drug development, and genomic studies to identify therapeutic targets.
Department of Computer Science Master's program. GRE scores are expected for international students.